Actively Recruiting

Age: 18Years +
All Genders
NCT05051098

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

Led by Hannover Medical School · Updated on 2025-03-13

3000

Participants Needed

1

Research Sites

238 weeks

Total Duration

On this page

Sponsors

H

Hannover Medical School

Lead Sponsor

E

European Union

Collaborating Sponsor

AI-Summary

What this Trial Is About

In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).

CONDITIONS

Official Title

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Hepatitis B Virus infection
  • For TherVacB sub-cohort: confirmed chronic hepatitis B with HBsAg positive for at least 1 year before joining
  • For TherVacB sub-cohort: documented HBeAg status for at least 6 months
Not Eligible

You will not qualify if you...

  • For TherVacB sub-cohort: age over 70 years
  • Co-infection with HIV or hepatitis C virus (RNA positive)
  • Clinically relevant liver diseases such as ALD, NASH, Haemochromatosis, Autoimmune hepatitis, AT1, Wilson's disease, primary biliary cirrhosis
  • Significant other illnesses like cancers
  • Receiving immunosuppressive treatment greater than 40 mg Cortisol-equivalent
  • Liver cirrhosis diagnosed clinically or by imaging
  • History of hepatocellular carcinoma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hannover Medical School

Hanover, Germany, 30625

Actively Recruiting

Loading map...

Research Team

P

Petra Dörge

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here